Bone cancer can be cured, especially when caught early and treated with surgery, chemotherapy, or radiation

Whether bone cancer is curable depends mainly on the type of cancer, how far it has spread, and how quickly treatment begins. The most common type in children and young adults — osteosarcoma — has a cure rate around 60 to 70 percent when treated with surgery plus chemotherapy before the cancer reaches other parts of the body. Ewing sarcoma, another common type, has similar outcomes. Older adults and people whose cancer has spread to the lungs or other organs face lower cure rates, but treatment can still extend life and manage symptoms.

Cure in cancer means the cancer does not return after treatment ends. Doctors cannot always promise a cure, but they can describe your individual chances based on your specific diagnosis, the size and location of the tumor, and whether it has spread. This conversation happens after imaging and biopsy results come back.

Key Takeaways

  • Osteosarcoma and Ewing sarcoma, the two most common bone cancers, have cure rates between 60 and 70 percent when treated early with surgery and chemotherapy.
  • Treatment usually combines surgery to remove the tumor with chemotherapy before and after surgery, and sometimes radiation.
  • Cure rates drop significantly if the cancer has spread to the lungs or other organs at the time of diagnosis.
  • Your doctor will give you a specific prognosis — your individual chance of cure — based on your tumor's size, location, and whether it has spread.
  • Long-term follow-up care after treatment ends is essential, because bone cancer can return months or years later.

How doctors measure the chance of cure

Doctors use survival rates to describe cure chances. A five-year survival rate means the percentage of people still alive five years after diagnosis. For osteosarcoma without spread, the five-year survival rate is roughly 60 to 70 percent. For Ewing sarcoma, it is similar. These numbers come from large groups of patients treated over many years, so your individual outcome may differ.

Your doctor will also look at prognostic factors — specific details about your tumor that predict how it will behave. These include the tumor's size, whether it has broken through the bone into soft tissue, and whether cancer cells are visible in the bloodstream. A smaller tumor caught before it spreads carries a much better prognosis than a large tumor that has already reached the lungs.

Age matters too. Children and teenagers with bone cancer generally have better outcomes than adults over 40, partly because their bodies tolerate aggressive chemotherapy better and partly because their cancers tend to be more responsive to treatment.

Surgery as the foundation of treatment

Surgery to remove the tumor is almost always the first step toward cure. The surgeon removes the cancer along with a margin of healthy bone and tissue around it to reduce the chance that cancer cells are left behind. For many patients, this means removing part of the bone but preserving the limb — for example, removing the upper part of the tibia (shin bone) but keeping the knee and lower leg.

In some cases, the tumor is in a location where removing enough bone would make the limb unusable, or the cancer has wrapped around major blood vessels or nerves. Then the surgeon may recommend amputation — removing the entire limb. This is less common now than it was 30 years ago, because chemotherapy often shrinks tumors enough to allow limb-sparing surgery.

After surgery, the bone heals, and the patient may need physical therapy to regain strength and movement. Reconstruction — using a metal implant, bone graft, or other material to replace the removed bone — happens during or shortly after the cancer surgery.

Chemotherapy before and after surgery

Chemotherapy uses strong drugs to kill cancer cells throughout the body. For bone cancer, it usually starts before surgery (called neoadjuvant chemotherapy) to shrink the tumor and kill any cancer cells that may have spread too small to see on imaging. After surgery heals, chemotherapy continues for several more months (called adjuvant chemotherapy) to destroy any remaining cells.

The drugs used most often for osteosarcoma are cisplatin, doxorubicin, and methotrexate, given in cycles over several months. Ewing sarcoma is often treated with a different combination: doxorubicin, cisplatin, etoposide, ifosfamide, and vincristine. The exact plan depends on the tumor type and your age and overall health.

Chemotherapy causes side effects — nausea, hair loss, low blood counts, and increased infection risk — but these are usually temporary. The benefit of killing cancer cells outweighs the temporary discomfort for most patients with bone cancer.

Radiation therapy and other treatment options

Radiation therapy uses high-energy beams to kill cancer cells in a specific area. It is not always used for bone cancer, but it may be recommended if the surgeon cannot remove all the cancer, if the tumor is in a sensitive location like the spine, or if the cancer returns after initial treatment.

For some patients with Ewing sarcoma, radiation to the original tumor site is part of the standard plan, especially if surgery is not possible. Newer radiation techniques like intensity-modulated radiation therapy (IMRT) focus the beam more precisely, reducing damage to healthy tissue nearby.

Targeted therapy and immunotherapy — newer drugs that work differently than chemotherapy — are being studied in clinical trials for bone cancer. Your oncologist can tell you whether any trials are open at your treatment center and whether you might be a candidate.

What happens after treatment ends

After surgery, chemotherapy, and radiation are complete, follow-up care becomes the focus. You will have imaging scans — usually X-rays and CT scans — every few months for the first year or two, then less often as time passes. These scans look for signs that the cancer has returned in the original location or spread to the lungs, where bone cancer most often recurs.

Blood tests may also be part of follow-up, depending on your tumor type. Some bone cancers produce markers — substances in the blood that rise when cancer is present — that can be tracked over time.

If the cancer does return, it can often be treated again with surgery, chemotherapy, or radiation. Second recurrences are harder to treat, but options still exist. This is why long-term follow-up is so important — catching a recurrence early gives the best chance of controlling it.

Factors that affect cure rates

The most important factor is whether the cancer has spread to other organs at diagnosis. If the cancer is only in the bone where it started, cure rates are 60 to 70 percent. If it has spread to the lungs — which happens in about 15 to 20 percent of cases — the cure rate drops to around 20 to 30 percent. Spread to other organs is even less common but carries an even lower prognosis.

Tumor size matters significantly. Tumors smaller than 8 centimeters have better outcomes than larger ones. The location also plays a role: tumors in the femur (thighbone) or tibia (shinbone) tend to have slightly better outcomes than tumors in the pelvis, which are harder to remove completely.

How well the tumor responds to chemotherapy — measured by how much it shrinks before surgery — is another strong predictor. Tumors that shrink by more than 90 percent have better cure rates than those that shrink less.

Life after bone cancer treatment

Many people treated for bone cancer return to school, work, and normal activities. If you had limb-sparing surgery, you may need physical therapy for months to regain strength and range of motion. If you had amputation, you will work with a prosthetist to fit and adjust an artificial limb, and physical therapy helps you learn to use it.

Long-term side effects depend on the treatment. Chemotherapy can affect the heart, hearing, and fertility. Radiation can increase the risk of a second cancer years later in the area that was treated. Your oncology team will discuss these risks and recommend screening or preventive steps.

Emotional recovery is also important. Many young people treated for bone cancer benefit from counseling or support groups to process the experience and adjust to life after cancer.

Frequently Asked Questions

Can bone cancer come back after successful treatment?

Yes. Bone cancer can recur in the original location or spread to the lungs months or years after treatment ends. This is why follow-up imaging scans continue for years. If recurrence is caught early, it can often be treated again with surgery or chemotherapy.

What is the difference between osteosarcoma and Ewing sarcoma?

Both are common bone cancers in children and young adults, but they arise from different cell types and are treated slightly differently. Osteosarcoma usually occurs in the femur or tibia; Ewing sarcoma can occur in any bone. Both are treated with surgery and chemotherapy, and both have similar cure rates when caught early.

Does age affect the chance of cure?

Yes. Children and teenagers generally have better outcomes than adults over 40, partly because their bodies tolerate chemotherapy better and partly because their tumors tend to respond more strongly to treatment. Older adults may also have other health conditions that limit treatment options.

What if the tumor cannot be removed completely with surgery?

If surgery alone cannot remove all the cancer, radiation therapy is often added to kill remaining cells. In some cases, chemotherapy may shrink the tumor enough to allow a second surgery. Your oncologist will discuss the best approach based on the tumor's location and size.

Will I need chemotherapy if my tumor is small and has not spread?

Almost certainly yes. Even small tumors without visible spread often contain microscopic cancer cells that have left the original site. Chemotherapy before and after surgery significantly improves cure rates, which is why it is standard treatment for bone cancer regardless of tumor size.